Abstract:Objective To investigate the inhibitory effect of ginsenoside Rg3 combined with cisplatin (DDP) on DDP-resistant cell line SGC-7901/DDP and their molecular mechanism.Methods SGC-7901/DDP cells were divided into four groups including a control group,a ginsenoside Rg3 (40 μg/ml) treatment group,a DDP (1.40 μg/ml) treatment group,and a drug combination treatment group.The proliferation ability of SGC-7901/DDP cells was detected by MTT,EdU,and colony formation assays.The apoptosis ability of SGC-7901/DDP cell was detected by flow cytometry and Hoechst 33342 staining.The protein levels of apoptosis-related markers were detected by Western blotting.The migration ability of SGC-7901/DDP cells was detected by wound healing and Transwell assays.The expression levels of proteins in epithelial-mesenchymal transformation (EMT) and Wnt/β-catenin signaling pathway were determined by Western blotting and immunofluorescence staining.Results Compared with the ginsenoside Rg3 or the DDP treatment groups,the drug combination treatment group inhibited the proliferation (t=8.062,P=0.001;t=7.090,P=0.002),colony formation (t=8.062,P=0.001;t=6.144,P=0.004),and migration (t=7.424,P=0.002;t=4.317,P=0.013),and promoted the apoptosis (t=5.530,P=0.031;t=6.036,P=0.026) of SGC-7901/DDP cells.Compared with the ginsenoside Rg3 and the DDP treatment groups,the drug combination treatment group down-regulated the expression levels of EMT-associated proteins including vimentin (t=24.450,P<0.001;t=14.750,P<0.001),Snail (t=29.640,P<0.001;t=70.700,P<0.001),Slug (t=89.230,P<0.001;t=87.360,P<0.001),matrix metalloproteinase (MMP) 2 (t=84.540,P<0.001;t=67.120,P<0.001),and MMP9 (t=19.010,P<0.001;t=10.890,P<0.001),as well as those of Wnt/β-catenin signaling pathway related proteins including Wnt (t=35.480,P<0.001;t=14.670,P<0.001),β-catenin (t=155.800,P<0.001;t=118.100,P<0.001),C-myc (t=20.870,P<0.001;t=3.334,P=0.029),and cyclin D1 (t=5.007,P=0.008;t=8.347,P=0.001).Meanwhile,it up-regulated the expression of epithelial cells including E-cadherin (t=36.450,P<0.001;t=33.810,P<0.001) and ZO-1 (t=37.060,P<0.001;t=37.030,P<0.001).Conclusion Ginsenoside Rg3 enhanced the sensitivity of SGC-7901/DDP cells to DDP by inhibiting the activity of Wnt/β-catenin signaling pathway.

Ercc1 Sirna Ameliorates Drug Resistance to Cisplatin in Gastric Carcinoma Cell Lines

Effects of Lncrna ANRIL-knockdown on the Proliferation, Apoptosis and Cell Cycle of Gastric Cancer Cells.

Resveratrol Synergizes with Cisplatin in Antineoplastic Effects Against AGS Gastric Cancer Cells by Inducing Endoplasmic Reticulum Stress‑mediated Apoptosis and G2/M Phase Arrest.

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-complementing Gene 1 in Lung Cancer Cell A549/DDP

Downregulation of Microrna-17-5p Inhibits Drug Resistance of Gastric Cancer Cells Partially Through Targeting P21.

ERCC1 targeted RNA interference reversing cisplatin resistance in human lung adeno-carcinoma cells

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-Complementing 1 Gene in Ovarian Cancer Cell Lines

[Relationship Between ERCC1 Expression and Cisplatin Intervention in Human Lung Adenocarcinoma Cell Lines].

[Relationship Between Nucleotide Excision Repair Gene ERCC1 and Resistance to Cisplatin in Ovarian Cancer].

Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin

The Effects of ERCC1 Expression Levels on the Chemosensitivity of Gastric Cancer Cells to Platinum Agents and Survival in Gastric Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy

Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells

Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.

Observation on sensitivity of human gastric cancer SGC-7901 cells to cisplatin by RNAi techniques

Silencing MRP4 by Small Interfering RNA Reverses Acquired DDP Resistance of Gastric Cancer Cell.

Targeting Oncogenic Mir-181A-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer.

Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.

Exosomes Serve As Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.

Chemoresistance in Gastric Cancer is Attributed to the Overexpression of Excision Repair Cross-Complementing 1 (ERCC1) Caused by Microrna-122 Dysregulation

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.

[Ginsenoside Rg3 Regulates Cisplatin Resistance in Gastric Cancer by Wnt/β-catenin Signaling Pathway].